This is the first completed phase III trial of an oral, small-molecule GLP-1 receptor agonist in people with obesity, Wharton ...

Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing ...

Elevated levels of the gut hormone GLP-1 and its receptor may worsen brain inflammation and trigger severe symptoms in patients with neuromyelitis optica spectrum disorder (NMOSD), suggesting GLP-1 ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

The weight-loss drug boom has, in many ways, turned into a generational market story. For perspective, the U.S. obesity ...

Novo Nordisk (NVO) plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with addiction, Martin Holst Lange, the Danish pharma’s head of development, told an ...

Studies states that consuming Palatinose (isomaltulose) improves the body’s hormonal and glycemic response to a second meal ...

The National Institutes of Health’s flagship long COVID initiative, RECOVER—short for Researching COVID to Enhance ...

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Our Lady of the Lake Health in Baton Rouge announced the completed installation of new technology that brings automation to ...